Baseline Predictors for One Year Visual Outcomes with Ranibizumab or Bevacizumab for Neovascular Age-related Macular Degeneration

OBJECTIVE: To determine baseline predictors of visual acuity (VA) outcomes at 1 year after treatment with ranibizumab or bevacizumab for neovascular age-related macular degeneration (AMD). DESIGN: Cohort study within the Comparison of AMD Treatments Trials. PARTICIPANTS: 1105 participants with neova...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Ying, Gui-shuang, Huang, Jiayan, Maguire, Maureen G., Jaffe, Glenn J., Grunwald, Juan E., Toth, Cynthia, Daniel, Ebenezer, Klein, Michael, Pieramici, Dante, Wells, John, Martin, Daniel F.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2012
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3536921/
https://ncbi.nlm.nih.gov/pubmed/23047002
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ophtha.2012.07.042
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller